Similar articles

• Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.

  Rothberg MB, Bellantonio S, Rose DN. Rothberg MB, et al. Ann Intern Med. 2003 Sep 2;139(5 Pt 1):321-9. doi: 10.7326/0003-4819-139-5_part_1-200309020-00007. Ann Intern Med. 2003. PMID: 12965940
• Summaries for patients. Influenza vaccination or antiviral treatment for healthy working adults: an economic analysis.

  [No authors listed] [No authors listed] Ann Intern Med. 2002 Aug 20;137(4):I22. doi: 10.7326/0003-4819-137-4-200208200-00001. Ann Intern Med. 2002. PMID: 12186536 No abstract available.
• What is the best antiviral agent for influenza infection?

  Fagan HB, Moeller AH. Fagan HB, et al. Am Fam Physician. 2004 Oct 1;70(7):1331-2. Am Fam Physician. 2004. PMID: 15508545 Review. No abstract available.
• Antiviral therapy for influenza virus infections.

  Prober CG. Prober CG. Semin Pediatr Infect Dis. 2002 Jan;13(1):31-9. doi: 10.1053/spid.2002.29755. Semin Pediatr Infect Dis. 2002. PMID: 12118841 Review.
• Cost-effectiveness of newer treatment strategies for influenza.

  Smith KJ, Roberts MS. Smith KJ, et al. Am J Med. 2002 Sep;113(4):300-7. doi: 10.1016/s0002-9343(02)01222-6. Am J Med. 2002. PMID: 12361816